financetom
Business
financetom
/
Business
/
China's Zhipu AI launches free AI agent, intensifying domestic tech race
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's Zhipu AI launches free AI agent, intensifying domestic tech race
Mar 30, 2025 10:36 PM

BEIJING (Reuters) - Chinese artificial intelligence startup Zhipu AI unveiled a free AI agent on Monday, joining a wave of similar launches in China's increasingly competitive AI market.

The product, called AutoGLM Rumination, can perform deep research as well as tasks including web searches, travel planning, and research report writing, CEO Zhang Peng said at a lunch event in Beijing.

The agent is powered by Zhipu's proprietary models, including its reasoning model GLM-Z1-Air and foundation model GLM-4-Air-0414. The company claims GLM-Z1-Air matches rival DeepSeek's R1 in performance while running up to eight times faster and requiring only one-thirtieth of the computing resources.

AI agents are systems designed to make decisions and execute a range of tasks autonomously.

The launch follows a surge in Chinese AI product releases after DeepSeek shook the industry earlier this year with a model that it said operated at substantially lower costs than U.S. rivals.

It also comes weeks after competitor Manus sparked interest with what it marketed as the world's first general AI agent.

While Manus charges users up to $199 monthly, Zhipu's AutoGLM Rumination will be available free of charge through the company's official channels, including its GLM model website and mobile app.

Zhipu AI, founded in 2019 as a spinoff from a Tsinghua University laboratory, has emerged as one of China's leading AI startups.

The company, which developed the GLM series of models, claims its latest large language model GLM4 outperforms OpenAI's GPT-4 on several benchmarks.

The startup made headlines earlier this month after securing three consecutive rounds of government-backed funding in a single month. The most recent investment came from the city of Chengdu, which injected 300 million yuan ($41.5 million) into the company.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KE Q4 Adjusted Net Income, Net Revenue Fall
KE Q4 Adjusted Net Income, Net Revenue Fall
Mar 16, 2026
06:18 AM EDT, 03/16/2026 (MT Newswires) -- KE (BEKE) reported Q4 adjusted net income Monday of 0.46 Chinese renminbi ($0.07) per diluted American depositary share, down from 1.14 renminbi a year earlier. Analysts polled by FactSet expected 0.73 renminbi. Net revenue for the quarter ended Dec. 31 was 22.19 billion renminbi, compared with 31.13 billion renminbi a year earlier. Analysts...
National Energy Services Reunited Gets $300 Million in Cementing Contracts
National Energy Services Reunited Gets $300 Million in Cementing Contracts
Mar 16, 2026
06:22 AM EDT, 03/16/2026 (MT Newswires) -- National Energy Services Reunited ( NESR ) said Monday it has secured several, multi-year cementing contracts of about $300 million. These awards include several awards in Kuwait and in North Africa. Shares of the company rose more than 1% in recent Monday premarket activity. ...
Update: Market Chatter: Meta Delays Launch of AI Model Due to Performance Concerns
Update: Market Chatter: Meta Delays Launch of AI Model Due to Performance Concerns
Mar 16, 2026
06:20 AM EDT, 03/16/2026 (MT Newswires) -- (Updates with Meta's response in the fourth paragraph.) Meta Platforms ( META ) has postponed the launch of its Avocado artificial intelligence model to at least May as the AI tool fell short of internal tests, The New York Times reported late Thursday, citing three people familiar with the matter. Avocado has not...
Market Chatter: Amgen, GSK Join TrumpRx.gov With Deep Drug Discounts
Market Chatter: Amgen, GSK Join TrumpRx.gov With Deep Drug Discounts
Mar 16, 2026
06:17 AM EDT, 03/16/2026 (MT Newswires) -- Amgen ( AMGN ) and GSK (GSK) will be added to TrumpRx.gov, expanding the list of discounted prescription drugs to 54 medications from six companies, Fox Business reported Monday. Amgen ( AMGN ) will cut Amjevita 80% to $299 and discount Aimovig and Repatha by 62%, according to the report. GSK will discount...
Copyright 2023-2026 - www.financetom.com All Rights Reserved